Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
18%
Angiotensin II
9%
Antioxidant
17%
Biological Marker
9%
Cancer Growth
45%
Chemotherapy
10%
Chondroitin Sulfate
9%
Chronic Obstructive Lung Disease
12%
Cigarette Smoke
14%
Colorectal Cancer
11%
Diabetes Mellitus
14%
Extracellular Superoxide Dismutase
18%
Fatty Acid Binding Protein
9%
Fibrosis
24%
Hydrogen Peroxide
10%
Hyperglycemia
15%
Hypoxia-Induced Pulmonary Hypertension
9%
Inflammasome
9%
Inflammation
14%
Iodine-131
9%
Malignant Neoplasm
48%
Manganese Superoxide Dismutase
9%
Metalloporphyrin
9%
Metastasis
9%
Microparticle
9%
Mouse
55%
Neoplasm
36%
Overall Survival
9%
Porphyrin
58%
Prostate Cancer
100%
Prostate Tumor
13%
Pseudomonas aeruginosa
9%
Radiation Exposure
23%
Radiation Induced Fibrosis
16%
Radiation Injury
26%
Reactive Oxygen Metabolite
32%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
9%
Side Effect
14%
Sirtuin
9%
Skin Allergy
9%
Superoxide
15%
Superoxide Dismutase
34%
Surfactant Protein A
9%
Surfactant Protein D
9%
Tamsulosin
9%
Thiol
15%
Thyroid Cancer
9%
Transcription Factor Nrf2
9%
Transforming Growth Factor
9%
Transient Receptor Potential Channel M3
9%
Medicine and Dentistry
Addictive Behavior
9%
Adipocyte
10%
Adiponectin
18%
Antioxidant
21%
Arthrofibrosis
9%
Articular Cartilage
9%
Blood Pressure
9%
Breast Carcinoma
9%
Cancer Cell
23%
Cancer Growth
20%
Cancer Therapy
11%
Cancer Treatment
5%
Cell Death
8%
Chemotherapy
10%
Colorectal Cancer
9%
Cytotoxicity
9%
Diabetes Mellitus
9%
Female Reproductive Tract
9%
Fibroblast
22%
Fibrosis
11%
Hyperglycemia
5%
Hypoxia-Induced Pulmonary Hypertension
9%
Injury
7%
Iodine 131
9%
Malignant Neoplasm
19%
Memory Consolidation
6%
Metalloporphyrin
9%
Neoplasm
27%
Neutrophil
9%
Overall Survival
9%
Oxidative Stress
22%
Porphyrin
36%
Prostate Cancer
61%
Prostate Tissue
11%
Radiation Injury
21%
Radiation Therapy
36%
Radioprotector
6%
Reactive Oxygen Species
23%
Secretion (Process)
9%
Side Effect
21%
Superoxide
13%
Superoxide Dismutase
28%
Sympathetic Nerve
5%
Thyroid Cancer
9%
Tissue Injury
6%
Treatment Response
9%
Tumor Cell
8%
Tumor Progression
10%
Vasodilatation
9%
Water Maze
6%
Keyphrases
131I Therapy
9%
Advanced Prostate Cancer
9%
Allergic Dermatitis
9%
Androgen-independent
10%
Antioxidant
12%
Arthrofibrosis
9%
Asthma Model
9%
BIRC5
9%
BMX-001
9%
Cachexia
9%
Cancer Cachexia
9%
Cancer Growth
9%
Castration Resistance
9%
Chronic Fibrosis
9%
Chronic Hypoxia-induced Pulmonary Hypertension
9%
Chronic Obstructive Pulmonary Disease
9%
Endogenous Enzymes
9%
Epigenetic Modification
9%
Fatty Acid-binding Protein 5 (FABP5)
9%
Heme oxygenase-1 (HO-1)
9%
IFN1
9%
IL-29
9%
Injury Biomarkers
9%
Interleukin-32 (IL-32)
9%
Manganese Porphyrin
9%
Metalloporphyrin
9%
MnTe
9%
Mycobacterium Avium Complex Lung Disease
9%
NADPH Depletion
9%
NADPH Oxidase 4 (NOX4)
9%
NALP3 Inflammasome
9%
Normal Prostate
9%
Omics Profiles
9%
P66Shc
18%
PAI-1 Gene
9%
Pro-oxidant
11%
Prostate Cancer
10%
Prostate Cancer Cells
13%
Prostate Cancer Progression
11%
Prostate Fibroblasts
9%
Prostate Tissue
9%
Radiation Countermeasures
9%
Radiation Damage
9%
Radiation Fibrosis
9%
Rapid Endothelialization
9%
Reactive Oxygen Species
12%
Recruited Macrophages
9%
Signaling Axis
9%
Superoxide Dismutase Mimic
9%
Vascular Activation
9%